Clinical Trials on AML/MDS in United Kingdom
Total 168528 results
-
Montefiore Medical CenterRecruitingAML | MDSUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
Cell Medica LtdUniversity College, London; Cell Therapy CatapultCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)United Kingdom, Germany, Belgium
-
Sigilon Therapeutics, Inc.WithdrawnMPS I | MPS1-S | MPS1-HSBrazil, United Kingdom
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndromes (MDS)United States, Australia, Canada, France, Germany, Italy, United Kingdom
-
Dana-Farber Cancer InstituteCompletedMyelodysplastic Syndromes (MDS)United States
-
Michael SavonaIncyte Corporation; Astex Pharmaceuticals, Inc.; TheradexRecruiting
-
Alexion PharmaceuticalsTerminatedMucopolysaccharidosis III, Type B (MPS IIIB) | Sanfilippo BUnited Kingdom
-
Alexion PharmaceuticalsCompletedMPS IIIB (Sanfilippo B Syndrome)United Kingdom
-
Genzyme, a Sanofi CompanyTerminatedMyelodysplastic Syndrome (MDS)Germany, United Kingdom, France, Netherlands
-
Sumitomo Pharma America, Inc.TerminatedMyelodysplastic Syndromes (MDS)United States
-
PersImmune, IncUniversity of California, San DiegoUnknown
-
Inmune Bio, Inc.TerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Cancer | AML | MDS-EBUnited Kingdom, Greece
-
ShireCompletedMucopolysaccharidosis (MPS)United Kingdom, Netherlands
-
SCRI Development Innovations, LLCNovartis PharmaceuticalsTerminated
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene CorporationTerminatedMyelodysplastic Syndrome | MDS | Low to Intermediate-1 MDS | Non-deletion 5qUnited States
-
Immune System Key LtdUniversity of Miami Sylvester Comprehensive Cancer CenterRecruitingAML | Advanced MDSUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Suspended
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingMyelodysplastic Syndrome (MDS) | Severe Aplastic Anemia | Hypo-Plastic MDSUnited States
-
Coeptis TherapeuticsDuke UniversityRecruitingMDS | AML, Adult RecurrentUnited States
-
Fujifilm Pharmaceuticals U.S.A., Inc.CompletedAML | MDS | CMMLUnited States
-
Cyclacel Pharmaceuticals, Inc.SuspendedLeukemia | Myelodysplastic Syndrome(MDS)United States
-
Celyad Oncology SAIQVIA BiotechCompletedAML | MDSUnited States, Belgium
-
Mana TherapeuticsTerminated
-
Cytheris, Inc.CompletedAML | MDS | CMLUnited States
-
Kiadis PharmaNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsWithdrawnMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)United States
-
AbbVieCelgene; Genentech, Inc.CompletedMyelodysplastic Syndromes (MDS)United States, Australia, Germany
-
Aptevo Research and Development LLCRecruiting
-
Spectrum Health HospitalsVan Andel Research Institute; Community Foundation for Southeast Michigan (JP...CompletedAML | MDS | Myeloproliferative DisorderUnited States
-
Synta Pharmaceuticals Corp.CompletedMyeloproliferative Disorders | AML | MDS | CMLUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Center for Research Resources (NCRR); Otsuka Pharmaceutical Co., Ltd.CompletedMDS | Lymphomas | LeukemiasUnited States
-
Jacqueline Garcia, MDNational Institutes of Health (NIH)RecruitingAcute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS) | Hematopoietic Stem Cell Transplant | MDS/Myeloproliferative Neoplasm-unclassifiable (MDS/MPN-unclassifiable)United States
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI)RecruitingMyelodysplastic Syndromes (MDS)United States, Israel
-
Stanford UniversityCelgene CorporationTerminatedLeukemia | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)United States
-
Anjali SharathkumarAmgenActive, not recruitingThrombocytopenia | Bone Marrow Failure Disorders | Aplastic Anemia | Refractory Cytopenia of Childhood | Myelodysplastic Syndrome(MDS)United States
-
Mirati Therapeutics Inc.TerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States, Canada, United Kingdom
-
University of Illinois at ChicagoRecruitingAcute Leukemia | MDSUnited States
-
Gwynn Long, M.D.ADC Therapeutics S.A.TerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS) | Myeloproliferative Neoplasm (MDS/MPN)United States
-
M.D. Anderson Cancer CenterRecruitingB-Cell Lymphoma | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)United States
-
Astex Pharmaceuticals, Inc.CompletedAML | MDS | CMMLUnited States, Canada
-
Prof. Janet DunnKing's College Hospital NHS Trust; University of Manchester; University of Birmingham and other collaboratorsRecruitingMyelodysplastic Syndromes (MDS)United Kingdom
-
PureTechRecruiting
-
University of California, San FranciscoCompleted
-
Cyclacel Pharmaceuticals, Inc.M.D. Anderson Cancer CenterCompleted
-
Radboud University Medical CenterRecruitingMyelodysplastic Syndromes (MDS)Denmark, Switzerland, Serbia, Austria, Croatia, Czechia, France, Germany, Greece, Israel, Italy, Netherlands, Poland, Portugal, Romania, Spain, Sweden, United Kingdom
-
Institut de Recherches Internationales ServierActive, not recruitingLeukemia, Myeloid, Acute | Untreated AML | Newly Diagnosed Acute Myeloid Leukemia (AML) | AML Arising From Myelodysplastic Syndrome (MDS)Spain, United States, France, Korea, Republic of, Taiwan, Australia, Canada, Germany, China, Italy, Austria, Czechia, Poland, Japan, United Kingdom, Russian Federation, Netherlands, Brazil, Israel, Mexico
-
PfizerCompletedAcute Myeloid Leukemia | Advanced MDSUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoWithdrawnLymphoma | Leukemia | MDSUnited States